Serotonin transporter, tryptophan hydroxylase, and monoamine oxidase A gene polymorphisms in premenstrual dysphoric disorder

American Journal of Obstetrics and Gynecology

Volumn 195, Issue 5, 2006, Pages 1254-1259

  Magnay, Julia L ^a   Ismail, Khaled M K ^b   Chapman, Gail ^b   Cioni, Leanne ^a   Jones, Peter W ^a   O'Brien, Shaughn ^b  

^a KEELE UNIVERSITY   (United Kingdom)

^b UNIVERSITY HOSPITAL OF NORTH STAFFORDSHIRE   (United Kingdom)

Author keywords

Monoamine oxidase; Polymorphism; Premenstrual dysphoric disorder; Serotonin transporter; Tryptophan hydroxylase

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; SEROTONIN TRANSPORTER; TRYPTOPHAN HYDROXYLASE;

3' UNTRANSLATED REGION; ADULT; ARTICLE; CHI SQUARE TEST; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA POLYMORPHISM; FEMALE; GENE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; PREMENSTRUAL DYSPHORIC DISORDER; PRIORITY JOURNAL; VARIABLE NUMBER OF TANDEM REPEAT;

ADULT; COHORT STUDIES; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MENTAL DISORDERS; MIDDLE AGED; MONOAMINE OXIDASE; POLYMORPHISM, GENETIC; PREMENSTRUAL SYNDROME; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; TRYPTOPHAN HYDROXYLASE;

EID: 33750313988     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2006.06.087     Document Type: Article

References (32)

1. Angst J., Sellaro R., Merikangas K.R., and Endicott J. The epidemiology of perimenstrual psychological symptoms. Acta Psychiatr Scand 104 (2001) 110-116
2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. (1994), American Psychiatric Association, Washington (DC)
3. Ashby Jr. C.R., Carr L.A., Cook C.L., Steptoe M.M., and Franks D.D. Alteration of platelet serotonergic mechanisms and monoamine oxidase activity in premenstrual syndrome. Biol Psychiatry 24 (1988) 225-233
4. Halbreich U., and Tworek H. Altered serotonergic activity in women with dysphoric premenstrual syndrome. Int J Psychiatry Med 23 (1993) 1-27
5. Parry B.L. The role of central serotonergic dysfunction in the aetiology of premenstrual dysphoric disorder: therapeutic implications. CNS Drugs 15 (2001) 277-285
6. Ho H., Olsson M., Westberg L., Melke J., and Erikkson E. The serotonin reuptake inhibitor fluoxetine reduces sex steroid-related aggression in female rats: an animal model of premenstrual irritability?. Neuropsychopharmacology 24 (2001) 502-510
7. Erikkson E., Alling C., Andersch B., Andersson K., and Berggren U. Cerebrospinal fluid levels of monoamine metabolites: a preliminary study of their relationship to menstrual cycle phase, sex steroids and pituitary hormones in healthy women and in women with PMS. Neuropsychopharmacology 11 (1994) 210-213
8. Fitzgerald M., Malone K.M., Harrison W.M., McBride P.A., Endicott J., Cooper T., et al. Blunted serotonin response to fenfluramine challenge in premenstrual dysphoric disorder. Am J Psychiatry 154 (1997) 556-558
9. Steege J.F., Stout A.L., Knight D.L., and Nemeroff C.B. Reduced platelet tritium-labeled imipramine binding sites in women with premenstrual syndrome. Am J Gynecol 167 (1992) 168-172
10. Dimmock P.W., Wyatt K.M., Jones P.W., and O'Brien P.M. Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: a systematic review. Lancet 356 (2000) 1131-1136
11. Halbreich U., and Endicott J. The relationship of dysphoric premenstrual changes to depressive disorders. Acta Psychiatr Scand 71 (1985) 331-338
12. Critchlow D.G., Bond A.J., and Wingrove J. Mood disorder and personality assessment in premenstrual dysphoric disorder. J Clin Psychiatry 62 (2001) 688-693
13. Pearlstein T.B., Frank E., Rivera-Tovar A., Thoft J.S., Jacobs E., and Miecqowski T.A. Prevalence of axis I and axis II disorders in women with late luteal phase dysphoric disorder. J Affect Disord 20 (1990) 129-134
14. Graze K.K., Nee J., and Endicott J. Premenstrual tension predicts future major depressive disorder. Am J Psychiatry 81 (1990) 210-212
15. Kendler K.S., Silberg M.C., Neale R.C., Kessler, Heath A.C., and Eaves L.J. Genetic and environmental factors in the aetiology of menstrual, premenstrual and neurotic symptoms: a population based twin study. Psychol Med 22 (1992) 85-100
16. Wilson C.A., Turner C.W., and Keye Jr. W.R. Firstborn adolescent daughters and mothers with and without premenstrual syndrome: a comparison. J Adolesc Health 12 (1991) 130-137
17. Melke J., Landen M., Baghei F., Rosmond R., Holm G., Bjorntorp P., et al. Serotonin transporter gene polymorphisms are associated with anxiety-related personality traits in women. Am J Med Genet 105 (2001) 458-463
18. Coyle N., Jones I., Robertson E., Lendon C., and Craddock N. Variation at the serotonin transporter gene influences susceptibility to bipolar affective puerperal psychosis. Lancet 356 (2000) 490-491
19. Battersby S., Ogilvie A.D., Blackwood D.H.R., Sehn S., Muqit M.M.K., Muir W.J., et al. Presence of multiple functional polyadenylation signals and a single nucleotide polymorphism in the 3′ untranslated region of the human serotonin transporter gene. J Neurochem 72 (1999) 1384-1388
20. Turecki G., Zhu Z., Tzenova J., Lesage A., Seguin M., Tousignant M., et al. TPH and suicidal behavior: a study in suicide completers. Mol Psychiatry 6 (2001) 98-102
21. Rubinsztein D.C., Leggo J., Goodburn S., Walsh C., Jain S., and Paykel E.S. Genetic association between monoamine oxidase A microsatellite and RFLP alleles in bipolar affective disorder: analysis and meta-analysis. Hum Mol Genet 5 (1996) 779-882
22. Endicott J, Harrison W. Daily record of severity of problems form. New York: Department of Research Assessment and Training, New York State Psychiatric Institute; 1990.
23. Heils A., Teufel A., Petri S., Stober G., Reiderer P., Bengel D., et al. Allelic variation of the human serotonin transporter gene expression. J Neurochem 66 (1996) 1-4
24. Lesch K.P., Balling U., Gross J., Strauss K., Wolozin B.L., Murphy D.L., et al. Organization of the human serotonin transporter gene. J Neural Transm 95 (1994) 157-162
25. Rotondo A., Mazzanti C.M., Nielson D.A., Schuebel K.E., Lezza A., Gemignani A., et al. Lack of association of promoter region variation in tryptophan hydroxylase and serotonin transporter with obsessive compulsive disorder and eating disorders. [Abstract]. Neuropsychiatric Genet 21 (1997) 621
26. Nielsen D.A., Jenkins G.L., Stefanisko K.M., Jefferson K.K., and Goldman D. Sequence, splice site and population frequency distribution analyses of the polymorphic human tryptophan hydroxylase intron 7. Mol Brain Res 45 (1997) 145-158
27. Sabol S.Z., Hu S., and Hamer D. A functional polymorphism in the monoamine oxidase A gene promoter. Hum Genet 103 (1998) 273-279
28. Hotamisligil G.S., and Breakefield X.O. Human monoamine oxidase A gene expression determines level of enzyme activity. Am J Hum Genet 49 (1991) 383-392
29. Melke J., Westberg L., Landen M., Sundblad C., Eriksson O., Baghei F., et al. Serotonin transporter gene polymorphisms and platelet [3H] paroxetine binding in premenstrual dysphoria. Psychoneuroendocrinol 28 (2003) 446-458
30. Marshall S.E., Bird T.G., Hart K., and Welsh K.I. Unified approach to the analysis of genetic variation in serotonergic pathways. Am J Med Genet (Neuropsychiatr Genet) 88 (1999) 621-627
31. Rees M., Norton N., Jones I., McCandless F., Scourfield J., Holmans P., et al. Association studies of bipolar disorder at the human serotonin transporter gene (hSERT; 5HTT). Mol Psychiatry 2 (1997) 398-402
32. Collier D.A., Arranz M.J., Sham P., Battersby S., Vallada H., Gill P., et al. The serotonin transporter is a potential susceptibility factor for bipolar affective disorder. Neuroreport 7 (1996) 1675-1679